OrphanDrug
OrphanDrug
Pharma Knowledge Base

autosomal recessive spastic paraplegia type 66

ORPHA: 401815

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with autosomal recessive spastic paraplegia type 66, sourced from HPO and Orphanet clinical annotations.

Gait disturbanceChronic sensorineural polyneuropathyCerebellar hypoplasiaTalipes equinovarusLower limb spasticitySpastic gaitHypoplasia of the corpus callosumImpaired vibration sensation in the lower limbsLimb hypertoniaProgressive spastic paraplegiaLower limb amyotrophyColpocephalyIntellectual disabilityAreflexia

Classification & Codes

Orphanet Code

ORPHA:401815
autosomal recessive spastic paraplegia type 66
OrphanetORPHA:401815
Treatments0 drug(s)
Symptoms on record14 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
autosomal recessive spastic paraplegia type 66 | OrphanDrug